Fujii_2000_Gen.Pharmacol_35_71

Reference

Title : YM905, a novel M3 antagonist, inhibits Ca2+ signaling and c-fos gene expression mediated via muscarinic receptors in human T cells - Fujii_2000_Gen.Pharmacol_35_71
Author(s) : Fujii T , Kawashima K
Ref : General Pharmacology , 35 :71 , 2000
Abstract :

Our earlier observations suggest that M3 muscarinic acetylcholine (ACh) receptors (mAChRs) are involved in Ca2+ signaling and regulation of c-fos gene expression in T lymphocytes. Here, we describe the effects of YM905, a novel M3 antagonist, on evoked Ca2+ signaling and c-fos gene expression in CEM human leukemic T cells. YM905 significantly inhibited increases in intracellular free Ca2+ evoked by 10 microM oxotremorine-M, an M1/M3 agonist (IC50=100 nM), and also inhibited 10 microM oxotremorine-M-induced upregulation of c-fos gene expression at 1 microM. These findings demonstrate that YM905 antagonizes the intracellular responses in T cells induced via mAChRs, possibly M3 receptors.

PubMedSearch : Fujii_2000_Gen.Pharmacol_35_71
PubMedID: 11707312

Related information

Citations formats

Fujii T, Kawashima K (2000)
YM905, a novel M3 antagonist, inhibits Ca2+ signaling and c-fos gene expression mediated via muscarinic receptors in human T cells
General Pharmacology 35 :71

Fujii T, Kawashima K (2000)
General Pharmacology 35 :71